Masaki Naganuma

Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients

Ḱazunori Toyoda, Masatoshi Koga, Masaki Naganuma et al. · Stroke · 2009 · 149 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy

Tomohisa Nezu, Masatoshi Koga, Jyoji Nakagawara et al. · Stroke · 2011 · 121 citations

Medicine, Neurology, Radiology +17

Early Neurological Deterioration within 24 Hours after Intravenous rt-PA Therapy for Stroke Patients: The Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry

Mayumi Mori, Masaki Naganuma, Yasushi Okada et al. · Cerebrovascular Diseases · 2012 · 116 citations

Medicine, Neurology, Pharmacotherapy +17

Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry

Masaki Naganuma, Masatoshi Koga, Yoshiaki Shiokawa et al. · Cerebrovascular Diseases · 2010 · 107 citations

Life Sciences, Nephrology, Renal Pathophysiology +16

Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA

Tomohisa Nezu, Masatoshi Koga, Kazumi Kimura et al. · Neurology · 2010 · 105 citations

Medicine, Neurology, Radiology +17